Comparison of the estrogenic potencies of standardized soy extracts by immature rat uterotrophic bioassay

Phytomedicine

Volumn 15, Issue 1-2, 2008, Pages 31-37

  de Lima Toccafondo Vieira, Manuela ^a   Duarte, Rodrigo Ferreira ^a   Campos, Ligia Maria Moreira ^a   Nunan, Elzíria de Aguiar ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Estrogenic potency; Isoflavone; Soy extract; Uterotrophic bioassay

Indexed keywords

AGLYCONE; ARACHIS OIL; DAIDZEIN; GENISTEIN; GLYCITEIN; GLYCOSIDE; ISOFLAVONE; PHYTOESTROGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CHEMICAL COMPOSITION; CONTROLLED STUDY; ESTROGEN ACTIVITY; EVALUATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; STANDARD; STANDARDIZATION; UTEROTROPHIC BIOASSAY; UTERUS; WISTAR ALBINO GLAXO RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTRADIOL ANTAGONISTS; ESTROGENS; FEMALE; ISOFLAVONES; ORGAN SIZE; PHYTOESTROGENS; PLANT EXTRACTS; RATS; RATS, WISTAR; SOYBEANS; UTERUS;

ARACHIS; GLYCINE MAX; RATTUS;

EID: 37349020930     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.06.006     Document Type: Article

References (32)

1. Albert A., Altabre C., Baro F., Buendia E., Cabero A., Cancelo M.J., Castelo-Branco C., Chantre P.M., Duran J., Haya P., Impert P., Julia D., Lanchares J.L., Llaneza P., Manubens M., Minano A., Quereda F., Ribes C., and Vasquez F. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine 9 (2002) 85-92
2. Branham W.S., Dial S.L., Moland C.L., Hass B.S., Blair R.M., Fang H., Shi L., Tong W., Perkins R.G., and Sheehan D.M. Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J. Nutr. 132 (2002) 658-664
3. Cassidy A., Hanley B., and Lamuela-Raventos R.M. Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health. J. Sci. Food Agric. 80 (2000) 1044-1062
4. César I.C., Braga F.C., Soares C.D.V., Nunan E.A., Pianetti G.A., Condessa F.A., Barbosa T.A.F., and Campos L.M.M. Development and validation of a RP-HPLC method for quantification of isoflavone aglycones in hydrolysed soy dry extracts. J. Chromatogr. B 836 (2006) 74-78
5. Diel P., Schukz T., Smolnikar K., Strunck A., Vollmer G., and Michna H. Ability of xeno- and phyto-estrogens to modulate expression of estrogen sensitive genes in rat uterus: estrogenicity profiles and uterotrophic activity. J. Steroid Biochem. Mol. Biol. 73 (2000) 1-10
6. Diel P., Schmidt S., Vollmer G., Janning P., Upmeier A., Michna H., Bolt H.M., and Degen G.H. Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens. Arch. Toxicol. 78 (2004) 183-193
7. Duncan A.M., Underhill K.E.W., Xu X., Lavalleur J., Phipps W.R., and Kurzer M.S. Modest hormonal effects of soy isoflavones in postmenopausal women. J. Clin. Encocrinol. Metab. 84 (1999) 3479-3484
8. Faure E.D., Chantre P., and Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 9 (2002) 329-334
9. Han K.K., Soares Jr. J.M., Haidar M.A., de Lima G.R., and Baracat E.C. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet. Gynecol. 99 (2002) 389-394
10. Huntley A.L., and Ernst E. Soy for the treatment of perimenopausal symptoms - a systematic review. Maturitas 47 (2004) 1-9
11. Kaari C., Haidar M.A., Soares Jr. J.M., Nunes M.G., Quadros L.G.A., Kemp C., Stavale J.N., and Baracat E.C. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 53 (2006) 49-58
12. Kanno J., Onyon L., Haseman J., Fenner-Crisp P., Asbhy J., and Owens W. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic response: phase 1. Environ. Health Perspect. 109 (2001) 785-794
13. Kanno J., Onyon L., Peddada S., Asbhy J., Jacob E., and Owens W. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ. Health Perspect. 111 (2003) 1530-1549
14. Krejikamp-Kaspers S., Kok L., Grobbee D.E., De Haan E.H.F., Aleman A., Lampe J.W., and Van Der Schouw Y.T. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292 (2004) 65-74
15. Kurzer M.S. Phytoestrogen supplement use by women. J. Nutr. 133 (2003) 1983S-1986S
16. Lydeking-Olsen E., Beck-Jensen J.E., Setchell K.D.R., and Holm-Jensen T. Soy milk or progesterone for the prevention of bone loss: a two year randomized, placebo-controlled trial. Eur. J. Nutr. 43 (2004) 246-257
17. Muthyala R.S., Ju Y.H., Sheng S., William L.D., Doerge D.R., Katzenellenbogen B.S., Helferich W.G., and Katzenellenbogen J.A. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 12 (2004) 1559-1567
18. Nikander E., Metsä-Heikkilä M., Ylikorkala O., and Tiitinen A. Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. J. Clin. Endocrinol. Metab. 89 (2004) 1207-1212
19. Peñalvo J.L., Nurmi T., and Adlercreutz H. A simplified HPLC method for total isoflavones in soy products. Food Chem. 87 (2004) 297-305
20. Quella S.K., Loprinzi C.L., Barton D.L., Knost J.A., Sloan J.A., and LaVasseur B.I. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group trial. J. Clin. Oncol. 18 (2000) 1068-1074
21. Scambia G., Mango D., Signorille P.G., Anselmi-Angeli R.A., Palena C., Gallo D., Bombardelli E., Morazzoni P., Riva A., and Mancuso S. Clinical effects of standardized soy extract in postmenopausal women: a pilot study. Menopause 7 (2000) 105-107
22. Secreto G., Chiechi L.M., Amadori A., Miceli R., Venturelli E., Valerio T., and Marubini E. Soy isoflavones and melatonin for the relief of climateric symptoms: a multicenter, double-blind, randomized study. Maturitas 47 (2004) 11-20
23. Selvaraj V., Zakroczymski M.A., Naaz A., Mukai M., Ju H.Y., Doerge D.R., Katzenellenbogen J.A., Helferich W.G., and Cooke P.S. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol. Reprod. 71 (2004) 966-972
24. Setchell K.D.R., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashead W.T., Kirschner A.S., Cassidy A., and Heubi J.E. Bioavailability of pure isoflavonas in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 131 (2001) 1362S-1375S
25. Setchell K.D.R., Clerici C., Lephart E.D., Cole S.J., Heenan C., Castellani D., Wolfe B.E., Nechemias-Zimmer L., Brown N.M., Lund T.D., Handa R.J., and Heubi J.E. S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr. 81 (2005) 1072-1079
26. Simons A.L., Renouf M., Hendrich S., and Murphy P.A. Metabolism of glycitein (7,4′-dihydroxy-6-methoxy-isoflavone) by human gut microflora. J. Agric. Food Chem. 53 (2005) 8519-8525
27. Song T.T., Hendrich S., and Murphy P.A. Estrogenic activity of glycitein, a soy isoflavone. J. Agric. Food Chem. 47 (1999) 1607-1610
28. Tham D.M., Gardner C.D., and Haskell W.L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83 (1998) 2223-2235
29. Upmalis D.H., Lobo R., Bradley L., Warren M., Cone H., and Lami C.A. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 7 (2000) 236-242
30. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288 (2002) 321-333
31. Yu-Ming C., Ho S.C., Lam S.S.H., So S.S.S., and Woo J.L.F. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass; a double blind, randomized, controlled trial. J. Clin. Endocrinol. Metab. 88 (2003) 4740-4747
32. Zubik I., and Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 77 (2003) 1459-1465